Cargando…
Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer’s Disease Mouse Model
One characteristic of Alzheimer’s disease (AD) is excessive accumulation of amyloid-β (Aβ) in the brain. Aβ brain accumulation is, in part, due to a reduction in Aβ clearance from the brain across the blood-brain barrier. One key element that contributes to Aβ brain clearance is P-glycoprotein (P-gp...
Autores principales: | Hartz, Anika M. S., Zhong, Yu, Shen, Andrew N., Abner, Erin L., Bauer, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028735/ https://www.ncbi.nlm.nih.gov/pubmed/29997495 http://dx.doi.org/10.3389/fnagi.2018.00186 |
Ejemplares similares
-
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
por: Ding, Yujie, et al.
Publicado: (2021) -
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
por: Vulin, Milica, et al.
Publicado: (2023) -
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
por: Tang, Fei, et al.
Publicado: (2017) -
ABC Transporters and the Alzheimer’s Disease Enigma
por: Wolf, Andrea, et al.
Publicado: (2012) -
Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer’s Disease
por: Lee, Jennifer, et al.
Publicado: (2018)